• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

除重症肌无力外的神经肌肉传递障碍

Disorders of neuromuscular transmission other than myasthenia gravis.

作者信息

Swift T R

出版信息

Muscle Nerve. 1981 Jul-Aug;4(4):334-53. doi: 10.1002/mus.880040410.

DOI:10.1002/mus.880040410
PMID:6114428
Abstract

Disorders of neuromuscular transmission in humans are caused by a wide variety of agents including systemic diseases, drugs, environmental toxins, animal envenomation, cations, and hormones. Some are genetically determined. Many are of known etiology. All such disorders interfere with one or more events in the sequence whereby a nerve impulse excites a muscle action potential. In many disorders of neuromuscular transmission, abnormal fatigue occurs, and some cases respond dramatically to treatment. Investigation of the microphysiology, microanatomy, and pharmacology of both normal and diseased neuromuscular junctions has increased our knowledge of these disorders.

摘要

人类神经肌肉传递障碍由多种因素引起,包括全身性疾病、药物、环境毒素、动物毒液、阳离子和激素。有些是由遗传决定的。许多病因已知。所有这些障碍都会干扰神经冲动激发肌肉动作电位这一过程中的一个或多个环节。在许多神经肌肉传递障碍中,会出现异常疲劳,有些病例对治疗反应显著。对正常和患病神经肌肉接头的微观生理学、微观解剖学和药理学研究,增加了我们对这些障碍的了解。

相似文献

1
Disorders of neuromuscular transmission other than myasthenia gravis.除重症肌无力外的神经肌肉传递障碍
Muscle Nerve. 1981 Jul-Aug;4(4):334-53. doi: 10.1002/mus.880040410.
2
The effects of snake venoms and their neurotoxins on the nervous system of man and animals.蛇毒及其神经毒素对人和动物神经系统的影响。
Contemp Neurol Ser. 1975;12:259-93.
3
The pharmacological basis for the treatment of myasthenia gravis.
Pharmacol Physicians. 1970 Jun;4(6):1-7.
4
Electrodiagnostic evaluation of patients with myasthenia gravis and related disorders.
Neurol Clin. 1985 Aug;3(3):557-72.
5
Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.重症肌无力:发病机制与原理之个人见解,第二部分
Muscle Nerve. 1978 Mar-Apr;1(2):151-6. doi: 10.1002/mus.880010208.
6
[Pathophysiology on the disorder of neuromuscular transmission defects].[神经肌肉传递缺陷障碍的病理生理学]
Rinsho Byori. 1995 Sep;43(9):902-9.
7
Variability of neuromuscular transmission in myasthenia gravis.重症肌无力中神经肌肉传递的变异性
Trans Am Neurol Assoc. 1973;98:83-6.
8
Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.4-氨基吡啶在疾病状态下对神经肌肉传递的促进作用。
Muscle Nerve. 1980 Mar-Apr;3(2):112-9. doi: 10.1002/mus.880030203.
9
[Neuromuscular disorders, especially myasthenia].
Tidsskr Nor Laegeforen. 1972 Apr 30;92(12):855-8.
10
Disorders of neuromuscular transmission: a review.神经肌肉传递障碍:综述
Arch Phys Med Rehabil. 1983 May;64(5):195-200.

引用本文的文献

1
Myasthenia-like syndrome induced by cardiovascular agents. Report of a case.
Ital J Neurol Sci. 1987 Apr;8(2):167-9. doi: 10.1007/BF02337592.
2
Neurologic complications of cardiovascular diseases.心血管疾病的神经系统并发症
J Natl Med Assoc. 1989 Feb;81(2):193-7.
3
Bilateral intracavernous carotid aneurysms presenting as pseudo-ocular myasthenia gravis.表现为假性眼肌型重症肌无力的双侧海绵窦内颈动脉瘤
Trans Am Ophthalmol Soc. 1989;87:445-57; discussion 457-62.
4
Myasthenia gravis associated with Charcot-Marie-Tooth neuropathy: report of a case.
Ital J Neurol Sci. 1992 Jun;13(5):431-3. doi: 10.1007/BF02312150.